ema prac tirzepatide naion review 2025 Meeting highlights from the Pharmacovigilance Risk Assessment Committee ( PRAC) 13-16 January ema semaglutide naion label update

Based on available evidence, tirzepatide does not appear to directly affect menopausal symptoms or interact with hormone replacement therapy, though no studi...

Join our private weight loss programme in Malvern & Worcester

Developments in the Indian market for diabetes and obesity drugs have been a center focus of attention in recent weeks, as Novo Nordisks cash cow recently lost its patent protection in the country.

This guide breaks down the top 10 foods to avoid when taking semaglutide during weight loss research -- and how to design a proper diet plan for the research.

Become a little more 'regular'

Graphic Abstract